The treatment landscape for advanced/metastatic breast cancer is rapidly evolving, leaving clinicians with the task of creating individualized treatment plans based on various patient-, disease-, and treatment-related factors. Tune in to hear expert faculty examine the latest clinical evidence for novel therapies and share insights for effective biomarker testing, guideline-recommended treatment decision-making, and adverse event management. Featuring expert strategies for selecting the optimal treatment based on individual patient factors and preferences, don’t miss this opportunity to learn best practices on advancing breast cancer care in federal and public health settings.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/breast-cancer-evaluating-integrating-new-treatment-approaches
- Start Date: 2024-02-23 06:00:00
- End Date: 2024-02-23 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.25 hours
AMA PRA Category 1 Credit™️: 1.25 hours
Nursing: 1.25 hours
Pharmacy: 1.25 hours - MOC Credit Details: ABIM - 1.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: AstraZeneca (Any division) - Amount: 10714.29 - Is Kind Support: False Source: Aveo Pharmaceuticals - Amount: 3214.29 - Is Kind Support: False Source: Bayer (Any division) - Amount: 1428.57 - Is Kind Support: False Source: Merck (Any division) - Amount: 10714.29 - Is Kind Support: False Source: Novartis Corporation Pharmaceuticals - Amount: 7142.86 - Is Kind Support: False Source: Seagen - Amount: 5357.14 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest